Supernus Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from diseases of the central nervous system (CNS).
07-13-2010 Supernus Pharmaceuticals Advances SPN812 into Phase IIa U.S. Clinical Trial for ADHD
Study Measures Safety and Tolerability of Non-Stimulant Therapy for Treatment of ADHD in Adults read more...
